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Progranulin (PGRN), also known as proepi-
thelin,  acrogranin,  or  prostate  cancer  cell–
  derived growth factor (He and Bateman, 2003), is 
a secreted protein that undergoes proteolysis to 
generate seven mutually homologous 6-kD pep-
tides, called GRNs or epithelins. Cysteine com-
prises 88 of PGRN’s 593 residues and forms six 
intramolecular disulfide bridges in each of the 
GRNs, giving them a compact globular structure 
(Tolkatchev et al., 2008). PGRN is expressed 
by epithelial cells, macrophages, and neurons. 
Expression analyses and experiments with the 
native or recombinant protein have implicated 
PGRN  in  embryonic  development,  tumori-
genesis, and wound healing (Daniel et al., 2000; 
Zhu et al., 2002; He and Bateman, 2003). A 
prominent role of PGRN in the regulation of 
inflammation was suggested by our discovery 
that neutrophil elastase and macrophage-derived 
secretory leukocyte protease inhibitor (SLPI) 
promote and prevent, respectively, the conver-
sion of PGRN to GRNs, and that recombinant 
PGRN inhibits neutrophil activation, whereas 
GRNs promote epithelial cell generation of neu-
trophil chemoattractants (Zhu et al., 2002).
Mutations in the PGRN gene were recently 
found to cause frontotemporal dementia (FTD), 
the second most common dementia in people 
under the age of 65 (Neary et al., 1998). FTD 
patients  experience  gradual  and  progressive 
changes in behavior and personality, followed by 
a cognitive decline, prominent language disor-
ders, and sometimes Parkinsonism, in association 
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Progranulin (PGRN) is a widely expressed protein involved in diverse biological processes. 
Haploinsufficiency of PGRN in the human causes tau-negative, ubiquitin-positive fronto-
temporal dementia (FTD). However, the mechanisms are unknown. To explore the role of 
PGRN in vivo, we generated PGRN-deficient mice. Macrophages from these mice released 
less interleukin-10 and more inflammatory cytokines than wild type (WT) when exposed to 
bacterial lipopolysaccharide. PGRN-deficient mice failed to clear Listeria monocytogenes 
infection as quickly as WT and allowed bacteria to proliferate in the brain, with corre-
spondingly greater inflammation than in WT. PGRN-deficient macrophages and microglia 
were cytotoxic to hippocampal cells in vitro, and PGRN-deficient hippocampal slices were 
hypersusceptible to deprivation of oxygen and glucose. With age, brains of PGRN-deficient 
mice displayed greater activation of microglia and astrocytes than WT, and their hippo-
campal and thalamic neurons accumulated cytosolic phosphorylated transactivation re-
sponse element DNA binding protein–43. Thus, PGRN is a key regulator of inflammation 
and plays critical roles in both host defense and neuronal integrity. FTD associated with 
PGRN insufficiency may result from many years of reduced neutrotrophic support together 
with cumulative damage in association with dysregulated inflammation.
©  2010  Yin  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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plifies exons 6 and 7 (Fig. 1 C, right). Immunostaining and 
Western blotting using polyclonal antibody against full-length 
PGRN confirmed that PGRN protein was markedly dimin-
ished in the brain (Fig. 1 D) and macrophages (Fig. 1 E) in 
PGRN-deficient mice. PGRN-deficient pups were born at 
the expected Mendelian frequency from hemizygous parents. 
Young-adult PGRN-deficient mice were healthy and fertile. 
Whole-body pathological evaluation was normal at the gross 
level, and there were no abnormalities in hematogram or se-
rum chemistries (Table S1).
PGRN-deficient macrophages produce more 
proinflammatory cytokines and less antiinflammatory  
IL-10 than WT macrophages
PGRN binds to and is protected from degradation by another 
macrophage product, SLPI (Zhu et al., 2002). Like recombi-
nant SLPI, recombinant PGRN has antiinflammatory effects 
(Jin et al., 1997; Zhu et al., 2002; Kessenbrock et al., 2008), 
but this function was only demonstrated by inhibition of neutro-
phil activation. To test the effect of depleting endogenous 
PGRN on inflammation, we stimulated bone marrow–derived 
macrophages (BMDMs) from PGRN-deficient mice with Toll-
like receptor (TLR) agonists. Compared with WT BMDMs, 
PGRN-deficient  BMDMs  had  similar  cell-surface  marker 
expression (Fig. S1) and phagocytic capacity (Fig. S2), but 
produced higher levels of transcripts and proteins for proin-
flammtory chemokines and cytokines such as monocyte che-
moattractant protein–1 (MCP-1), CXCL1, IL-6, IL-12p40, 
and TNF (Fig. 2, A and B). In contrast, production of the 
antiinflammatory cytokine IL-10 was largely suppressed in 
PGRN-deficient BMDMs at the mRNA and protein levels 
(Fig. 2 C). The enhanced inflammatory responses illustrated 
for LPS (a TLR4 agonist) were recapitulated with Pam3Cys-
SerLys4 (a ligand for TLR2), poly I:C (a ligand for TLR3), 
and  hypomethylated  bacterial  DNA  (a  ligand  for  TLR9;   
Fig. S3). Thus, antiinflammatory effects of PGRN can be 
extended from restraining the cytokine response of neutro-
phils (Zhu et al., 2002) to regulating the cytokine production 
of macrophages.
PGRN synergizes with LPS in inducing IL-10 expression  
in macrophages
To test whether insufficient IL-10 induction from PGRN-
deficient macrophages contributes to their overproduction 
of  inflammatory  cytokines,  we  stimulated  BMDMs  from 
WT and PGRN-deficient mice in the presence of a neutral-
izing antibody to IL-10 or control IgG. In the presence of 
anti–IL-10, WT macrophages produced as much TNF and 
MCP-1 as PGRN-deficient cells (Fig. 3 A), suggesting that 
compromised IL-10 production by PGRN-deficient macro-
phages does contribute to their hyperinflammatory phenotype. 
Next, we asked whether PGRN controls IL-10 expression 
at the transcriptional level. Nascent, unspliced IL-10 tran-
scripts from WT and PGRN-deficient BMDMs after LPS 
stimulation were compared by quantitative real-time RT-PCR 
using a primer pair spanning the exon 2/intron 2 boundary 
with progressive cortical atrophy, neuronal loss, astrocytic 
gliosis, and microglial activation (Neary et al., 1998). At least 
66 different pathogenic mutations in the PGRN gene have 
been documented in FTD patients, all of which resulted in 
functional null alleles and haploinsufficiency. These were as-
sociated with ubiqitinopathies, characterized by the deposit 
of ubiquitin-positive but tau-negative immunoreactivity in 
neuronal  cytoplasmic  and  neuronal  intranuclear  inclusions 
(Mackenzie et al., 2006; Cairns et al., 2007; Josephs et al., 
2007). One component of neuronal inclusions from PGRN-
linked FTD patients was identified as transactivation response 
element DNA binding protein–43 (TDP-43; Neumann et al., 
2006). Recent studies have linked pathological redistribution 
of TDP-43 from nuclei to cytoplasm to its phosphorylation 
and degradation (Cook et al., 2008; Hasegawa et al., 2008).
In this paper, we report that PGRN-deficient mice re-
sponded to infection with exaggerated inflammation. In vitro, 
their macrophages responded to microbial products by express-
ing enhanced levels of proinflammatory mediators and reduced 
antiinflammatory IL-10. Ex vivo, PGRN-deficient hippo-
campal neurons were more vulnerable than WT to metabolic 
stress. Finally, we detected microgliosis, astrocytosis, and cyto-
plasmic localization and phosphorylation of TDP-43 in the 
hippocampus and thalamus in aged PGRN-deficient mice 
but not in their WT counterparts. Thus, PGRN has a nonre-
dundant role in modulating inflammatory responses. Our 
studies raise the possibility that FTD may result in part from 
brain damage arising from the combination of dysregulated 
inflammation and heightened neuronal vulnerability.
RESULTS
Generation of PGRN-deficient mice
Complete human PGRN deficiency has not been identified. 
Accordingly, we chose to make conditional PGRN knock-
out mice with the expectation that pgrn gene deletion might 
be embryonic lethal. We flanked the pgrn locus with loxP 
sites to bracket the promoter and the first four exons in a 
bacterial artificial chromosome (BAC) targeting vector (Fig. 
1 A). Production of heterozygous and homozygous floxed 
mice was confirmed by Southern blotting (unpublished data). 
Generation of an all-tissue PGRN knockout was achieved by 
crossing pgrn floxed mice with mice transgenic for Cre re-
combinase driven by the promoter for the chicken actin gene 
(CAG; Fig. 1 B). This strategy left behind no neomycin re-
sistance gene, as well as no Cre transgene, which can impart 
a phenotype (Schmidt-Supprian et al., 2007). Mature oocytes 
of CAG-Cre transgenic females contain sufficient Cre activ-
ity to mediate the deletion of paternally derived LoxP-flanked 
DNA sequences upon fertilization, irrespective of the trans-
mission of the Cre transgene (Sakai and Miyazaki, 1997). In 
the mice used in this study, the PGRN-deficient mice and 
their WT littermates were Cre negative. PGRN mRNA levels 
in the knockout mice were undetectable in the intestine, spleen, 
skin, liver, kidney, and brain using a primer set that amplifies 
exons 7–10 (Fig. 1 C, left). Real-time RT-PCR likewise 
detected no messenger for PGRN using a primer set that am-JEM VOL. 207, January 18, 2010 
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(Zhu et al., 2002) on production of IL-10 from a mouse 
macrophage cell line, RAW264.7. Endotoxin-free PGRN 
alone did not induce IL-10 release by itself, but it synergized 
with LPS in a concentration-dependent fashion (Fig. 3 C). 
of the il-10 gene. Fig. 3 B shows an 70% reduction of nascent 
IL-10 transcripts in PGRN-deficient cells. Thus, the defect 
in IL-10 expression in these cells is at least in part transcrip-
tional. Finally, we tested the effect of recombinant PGRN 
Figure 1.  Generation of PGRN-deficient mice. (A) Mouse pgrn locus, targeting vector, and predicted floxed and deleted alleles. Gray boxes denote 
exons. Sequences are indicated for the neomycin/kanamycin resistance gene (neo/kan; light blue), diphtheria toxin/ampicillin gene (DTX/Amp; pink), LoxP 
sites (blue triangles), and flippase recombination target sites (red triangles). The red bar marks the 3 probe. (B) Genotyping of PGRN-deficient mice after 
crossing PGRN floxed mice with CAG-Cre mice. Genomic DNA was restricted with ScaI for Southern blotting with the 3 probe. Het, heterozygous; KO, 
homozygous knockout. (C) PGRN expression monitored by RT-PCR compared with GAPDH as a control (left). Quantification of PGRN transcripts in brain 
by real-time RT-PCR is shown (right). Results are means ± SEM. B, brain; In, intestine; K, kidney; Li, liver; Sk, skin; Sp, spleen. (D) Hippocampal (top) and 
cortical (bottom) sections from brains of WT and PGRN-deficient (KO) mice were stained with antibody against PGRN. Bar, 200 µm. (E) Mature BMDMs 
from 2-mo-old WT or PGRN-deficient mice (KO) were cultured in serum-free media for 48 h. Protein contents of conditioned media were blotted with 
anti-PGRN (right). Ponceau S staining of the same membrane is shown (left).120 Dysregulated inflammation in progranulin deficiency | Yin et al.
as  illustrated  in  the  liver  and  brain  (Fig.  4  D). Thus, 
PGRN-deficient mice may react to bacterial infections 
less efficiently than WT mice, resulting in excessive and 
prolonged inflammation.
Augmented age-dependent activation of microglia  
and astrocytes in the PGRN-deficient brain
To determine if there is any sign of dysregulated inflamma-
tion in the brains of PGRN-deficient mice, we examined the 
activation status of astrocytes and microglia, which help pro-
tect neurons from injury. Immunostaining of brain sections 
for myeloid antigen CD68, a marker for activated microglia, 
and glial fibrillary acidic protein (GFAP), an astrocytic marker, 
revealed little detectable difference between WT and PGRN-
deficient mice at 3 mo of age (Fig. S4). Both CD68 and 
GFAP staining increased slightly with age. This increase was 
far more pronounced in the absence of PGRN (Fig. 5 A), par-
ticularly in the hippocampus, cortex, and thalamus (Fig. 5 A), 
where the increases in CD68- and GFAP-positive cells were 
statistically significant (Fig. 5 B). The age-dependent, reactive 
phenotype of microglia and astrocytes in the PGRN-deficient 
brain may be a primary consequence of PGRN deficiency   
in microglia and astrocytes, a compensatory response to damage 
in PGRN-deficient neurons, or both. The next sets of ex-
periments explored these possibilities.
Thus, endogenous PGRN can serve as a negative regulator 
of inflammatory processes by helping to sustain the tran-
scription of IL-10 during inflammation.
Bacterial infection of PGRN-deficient mice leads  
to exaggerated inflammatory tissue damage  
and delayed recovery
To test the role of endogenous PGRN during inflammation 
in vivo, we infected mice with Listeria monocytogenes, an intra-
cellular pathogen widely used to study immune responses 
(Pamer, 2004; Serbina et al., 2008). PGRN-deficient mice 
had higher levels of MCP-1 in the serum, spleen, and brain 
than WT mice (Fig. 4 A). Paradoxically, high levels of MCP-
1 in PGRN-deficient mice did not lead to more monocyte 
infiltration  into  infected  organs.  On  the  contrary,  fewer 
monocytes were found in infected spleens of PGRN-deficient 
mice 24 h after infection (Fig. 4 B). This result is consistent 
with the report that overexpression of MCP-1 in trans-
genic mice disturbed the chemokine gradient and prevented 
timely monocyte infiltration into infected sites (Rutledge 
et al., 1995). As a consequence, PGRN-deficient mice had   
a high burden of Listeria in the spleen, liver, and brain at 5–7 
d  after  infection,  by  which  time  few  viable  bacteria  re-
mained in WT mice (Fig. 4 C). Persistence of the infection 
was associated with a more sustained inflammatory response, 
Figure 2.  Dysregulated inflammatory responses of PGRN-deficient macrophages to bacterial endotoxin in vitro. (A) Reduced cytokine expres-
sion by PGRN-deficient macrophages in response to LPS. Quantitative RT-PCR at indicated times after exposure to 10 ng/ml LPS is shown. (B) Reduced 
cytokine release by PGRN-deficient macrophages in response to LPS. ELISAs were done with conditioned media collected 12 or 24 h after adding the indi-
cated concentrations of LPS. (C) Enhanced IL-10 production by PGRN-deficient macrophages in response to LPS. IL-10 induction was determined as in A 
and B. Results are means ± SEM for triplicates from three to five similar experiments. *, P < 0.05 using the Student’s t test. ND, nondetectable.JEM VOL. 207, January 18, 2010 
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PGRN-deficient hippocampal slices are hypersusceptible  
to microglial activating agents and to deprivation of oxygen 
and glucose
To test whether PGRN-deficient microglia share this enhanced 
cell killing capacity, we expanded their numbers by treating 
hippocampal slices with GM-CSF for 3 d before adding LPS 
and IFN- (Duport and Garthwaite, 2005), and measured 
cell death 3 d later. Without GM-CSF pretreatment, minimum 
cell  death  was  observed.  After  GM-CSF  and  LPS/IFN- 
treatment, cytotoxicity was more pronounced in PGRN-
deficient hippocampal slices than in WT controls (Fig. 6 B). 
In the presence of neutralizing antibody against IL-10, WT mi-
croglia became as potent in killing hippocampal cells as PGRN-
deficient  microglia  (Fig.  6  B).  Thus,  like  macrophages, 
microglia cells control their inflammatory actions with bal-
anced production of pro- and antiinflammatory mediators, 
among which IL-10 is a key modulator. Neutralizing endog-
enous IL-10 made WT microglia as neurotoxic as PGRN-
deficient microglia.
To test the vulnerability of PGRN-deficient brain cells to 
a noninflammatory injury, we starved hippocampal slices for 
glucose and oxygen (Kawano et al., 2006; Kim et al., 2007). 
Cell death was greater in PGRN-deficient hippocampal 
tissues than in WT (Fig. 6 C). Thus, PGRN-deficient mi-
croglia respond to inflammatory stimuli by becoming more 
cytotoxic than WT microglia, and PGRN-deficient hippo-
campal tissues are more susceptible than WT to certain cyto-
toxic  stresses,  consistent  with  a  neurotrophic  role  of  this 
protein (Van Damme et al., 2008).
Increased ubiquitination and phosphorylation of TDP-43  
in the PGRN-deficient brain
A neuropathological feature associated with PGRN-haploin-
sufficient FTD is the appearance of ubiquitin-positive neuronal 
cytoplasmic and intranuclear inclusions (Mackenzie et al., 2006), 
whose major component is TDP-43 (Neumann et al., 2006). 
We found that staining for ubiquitin was elevated in the hippo-
campus and thalamus but not other regions of 18-mo-old WT 
and PGRN-deficient mice, but was much more pronounced in 
PGRN-deficient mice (Fig. 7 A and Fig. S5). In our study, nu-
clear TDP-43 was detected in the hippocampus and thalamus at 
a similar level in WT and PGRN-deficient mice using a poly-
clonal antibody against full-length TDP-43 (Fig. 7 B, top). 
Whether TDP-43 colocalized with ubiquitin was difficult to 
confirm, because ubiquitination of autofluorescent lipofuscin 
was increased in the absence of PGRN (Lewis et al., 2009). 
However, the most striking change was the appearance of phos-
pho–TDP-43 in the cytosol of neurons in the dentate gyrus   
and thalamus of aged PGRN-deficient but not aged WT mice 
(Fig. 7 B) or young PGRN-deficient mice (not depicted).
DISCUSSION
Contrary to expectations, PGRN proved to be dispensable 
during embryonic development of the mouse. This is consistent 
with the ability of another group to generate PGRN-defi-
cient mice as well (Kayasuga et al., 2007). That study described 
PGRN-deficient macrophages are more potent in killing 
hippocampal cells than WT macrophages
To test the potential impact of hyperinflammatory, PGRN-
deficient myeloid cells on the brain, we incubated hippo-
campal slices from neonatal WT mice with BMDMs from 
PGRN-deficient mice or their WT littermates and measured 
brain cell death 5 d later by propidium iodide (PI) staining. 
LPS and IFN- were added to activate BMDMs. Unstimu-
lated BMDMs caused minimal cell death. Stimulated WT 
BMDMs killed 18% of the cells in the hippocampal prep-
arations, whereas PGRN-deficient BMDMs killed 50% 
(Fig. 6 A). This result suggests that the ability of activated 
macrophages to kill hippocampal cells is augmented in the 
absence of PGRN, consistent with the link of this defi-
ciency to an exaggerated innate response phenotype (Fig. 2 
and Fig. 4).
Figure 3.  PGRN restrains macrophage inflammatory responses by 
synergizing with LPS for induction of IL-10 transcription. (A) Effect 
of anti–IL-10 antibody on TNF and MCP-1 production from BMDMs. 1 µg/
ml anti–IL-10 or control IgG was added together with LPS and cytokines 
quantitated by ELISA as in Fig. 2 B. Results are expressed as means ± SEM 
of triplicate samples from one out of four experiments. (B) PGRN regu-
lates IL-10 expression at the transcriptional level. Quantitative RT-PCR for 
nascent IL-10 transcripts (left) or spliced IL-10 transcripts (right) was 
measured 1 h after exposure of BMDMs to 100 ng/ml LPS. Results are 
expressed as means ± SEM of triplicate samples from one out of two 
independent experiments. (C) Recombinant PGRN synergized with LPS in 
IL-10 induction. RAW264.7 cells were incubated with the indicated con-
centrations of LPS and PGRN for 20 h. IL-10 in the conditioned media was 
measured by ELISA. Results are expressed as means ± SEM of three inde-
pendent experiments. *, P < 0.05 using the Student’s t test.122 Dysregulated inflammation in progranulin deficiency | Yin et al.
tory  function  in  large  part  by  synergizing  with  microbial 
products such as LPS to induce the transcription of IL-10, a 
major antiinflammatory cytokine. Further studies will address 
whether the immunodeficiency state we discovered in asso-
ciation with PGRN deficiency pertains to infectious agents 
other than L. monocytogenes.
Excessive proinflammatory responses have been impli-
cated in many neurodegenerative diseases (González-Scarano 
and Baltuch, 1999; Minghetti, 2005; Lobsiger and Cleveland, 
2007). In the brain, PGRN is widely expressed by different 
neuronal populations such as cortical and hippocampal pyra-
midal cells, as well as nonneuronal cells such as microglia. 
Trauma, malignancy, infection, and neurodegeneration are 
all associated with increased expression of PGRN in the brain 
(Liau et al., 2000; Ahmed et al., 2007; Pereson et al., 2009). 
The ability of PGRN to support resolution of inflammation 
only one phenotype: altered male sexual behavior. The phe-
notypes observed in the present study reveal a profound role 
for endogenous PGRN in the balanced production of anti- 
and proinflammatory cytokines and chemokines. Although 
PGRN has been previously reported to be antiinflammatory 
(Zhu et al., 2002; Kessenbrock et al., 2008), this function was 
only shown with respect to inhibition of neutrophil activation, 
and the inference was based on the provision of exogenous, 
recombinant PGRN. The present work extends PGRN’s 
antiinflammatory actions to inhibiting macrophage activation 
in vitro and global innate responses to bacterial infection in 
vivo, inferred in both cases from the effects of a loss of func-
tion mutation. Absence of PGRN led to overproduction of 
TNF and MCP-1 yet to a decreased ability to clear Listeria, 
with prolongation of inflammation in infected organs. In 
addition, we showed that PGRN exerted its antiinflamma-
Figure 4.  Defective host defense of PGRN-deficient mice. (A) Enhanced MCP-1 levels in PGRN-deficient mice in response to infection. WT and 
PGRN-deficient mice (n = 10 per group) were infected intravenously with 3 × 103 L. monocytogenes. MCP-1 levels in serum and spleen homogenates 
were determined 24 h after infection by ELISA. Hippocampal expression of MCP-1 was determined by real-time RT-PCR 5 d after infection and expressed 
as relative levels after normalization with GAPDH mRNA. Results are means ± SEM. *, P < 0.05 using the Student’s t test. ND, nondetectable. (B) Decreased 
monocyte recruitment to infected spleens of PGRN-deficient mice. Cells from naive or infected spleen (24 h after infection) were tested for the expression 
of CD11b and Ly6C (for monocyte population). Numbers in dot plots indicate the percentage of Ly6ChiCD11b+ cells. Dot plots are of individual mice; bar 
graphs represent the mean of five mice per group. Experiments were repeated three times with similar results. *, P < 0.05 using the Student’s t test.  
(C) Inability to rapidly resolve bacterial infection by PGRN-deficient mice. WT and PGRN-deficient (KO) mice were infected intravenously with 5 × 103  
L. monocytogenes. Bacterial burdens in the spleen, liver, and brain were measured as CFUs at the times indicated (n = 5 per genotype for days 3 and 5 
after infection; n = 10 per genotype for day 7 after infection). Results are means ± SEM from one out of three similar experiments. (D) Exaggerated tissue 
inflammation in PGRN-deficient mice, as assessed by hematoxylin and eosin staining at day 3 (liver) or 5 (brain) after intravenous infection with 5 × 103 
L. monocytogenes. Results are means ± SEM from one out of three similar experiments. Bars, 200 µm.JEM VOL. 207, January 18, 2010 
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several neuropathological features as they aged for 18 mo, a 
short time in comparison to the age of human adults with 
FTD. For example, the widespread activation of microglia 
and astrocytes in aged PGRN-deficient mice was reminis-
cent of FTD. Moreover, cortical ubiquitin- and TDP-43–
immunoreactive cytoplasmic or intranulear inclusions are 
common in FTD (Arai et al., 2006; Cairns et al., 2007;   
Josephs et al., 2007). We detected enhanced ubiquitination 
in the hippocampal and thalamic regions of aged PGRN-
deficient mice. In addition, we detected cytosolic phos-
phorylated TPD-43 in the hippocampus and thalamus of 
aged PGRN-deficient mice and not in WT mice. However, 
suggests that increased PGRN in these settings may reflect a 
compensatory, antiinflammatory response. This is supported 
by two findings. First, we observed augmented, spontaneous, 
age-dependent  activation  of  astrocytes  and  microglia  in 
PGRN-deficient mice. Second, peripheral infection by L. 
monocytogenes  resulted  in  much  greater  brain  involvement   
in PGRN-deficient than in WT mice. This invites the spec-
ulation that a state of PGRN insufficiency in humans may be 
permissive for brain damage accumulating over decades from 
repeated episodes of inflammation.
Even under conditions of husbandry intended to avoid 
intercurrent  infection,  PGRN-deficient  mice  developed 
Figure 5.  Augmented activation of microglia and astrocytes in the brain of aged PGRN-deficient mice. (A) Activation of microglia and astrocytes 
in PGRN-deficient mice. Hippocampal, cortical, and thalamic sections from 18-mo-old WT and PGRN-deficient (KO) mice (n = 6) were immunostained us-
ing antibody against CD68 or GFAP. (B) Activated CD68+ and GFAP+ cells were expressed as cells per square millimeter within indicated regions of both 
cerebral hemispheres of each animal. Results are means ± SEM from three independent experiments. *, P < 0.01 using the Student’s t test. Bar, 80 µm.124 Dysregulated inflammation in progranulin deficiency | Yin et al.
in contrast to FTD, we did not detect neuropathology in 
the prefrontal or cortical regions of PGRN-deficient mice, 
and their distribution of phosphorylated TDP-43 differed 
from that of TDP-43 inclusions in human FTD. Most strik-
ingly, our mice showed no evidence of cerebral atrophy 
within the period of study.
Aside from neuropathology, the mouse model in this 
study appears to differ from FTD in that no clinically ap-
parent  infectious  or  inflammatory  phenotype  has  been 
reported in FTD patients to our knowledge, apart from in-
creased MCP-1 and IL-8 levels in their cerebrospinal fluid 
(Galimberti et al., 2006). Perhaps the 50% deficiency of 
PGRN in FTD patients produces a less conspicuous de-
fect than the near-total PGRN deficiency in this study. 
Conversely, it is formally possible, though unlikely, that 
hemizygosity for PGRN would result in a more extreme 
neuropathologic  and  less  marked  immunoinflammatory 
phenotype in mice than the homozygous PGRN deficiency 
in this study. Additionally or alternatively, a phenotype of 
prolonged infectious or inflammatory states in FTD pa-
tients in the decades preceding the onset of neuropsychiat-
ric signs may have escaped attention. Our PGRN-deficient 
mice display specific behavioral abnormalities (unpublished 
data). It will be of interest to learn if those abnormalities 
progress as the mice age further, particularly under con-
ditions in which they may experience repetitive bouts of 
infection or inflammation. Such conditions are routine in 
the wild but not in our mouse colony (Perry et al., 2007; 
Björkqvist et al., 2008). In sum, the reasons for the differ-
ences between the mice described in this paper and human 
FTD deserve further study. However, it is worth noting 
that no mouse model has yet recapitulated all the features 
of a human neurodegenerative disease.
It  is  unknown  why  haploinsufficiency  in  PGRN,  a 
widely expressed protein, manifests chiefly by behavioral 
abnormalities and frontotemporal cerebral atrophy. A neu-
rotrophic  function  of  PGRN  was  first  suggested  by  the 
ability of PGRN to promote the growth of PC12 cells,   
a  pheochromocytoma-derived  neuronal  cell  line  (Daniel   
et al., 2000), and supported by the finding that granulin E 
improved survival and neurite growth of motor neurons in 
vitro (Van Damme et al., 2008). In this study, we demon-
strated that PGRN-deficient macrophages, when activated, 
were more potent than WT macrophages in killing hippo-
campal  neurons  in  co-culture.  Moreover,  neurons  from 
PGRN-deficient mice were more vulnerable to damage by 
activated microglia and by the depletion of oxygen and glu-
cose.  Whether  neurons  from  other  regions  of  the  brain 
share this vulnerability remains to be tested. Thus, FTD 
may arise from the congruence of two independent pheno-
types of PGRN insufficiency: dysregulated inflammation 
and increased neuronal vulnerability to damage.
MATERIALS AND METHODS
Construction of a BAC targeting vector. A BAC clone containing the 
mouse WT pgrn locus was obtained from the Wellcome Trust Sanger Institute. 
Figure 6.  Enhanced neurotoxic potential of PGRN-deficient macro-
phages and microglia, and increased vulnerability of PGRN-deficient 
neurons to stress. (A) BMDM-induced cell death in cultured hippocampal 
slices. WT coronal hippocampal slices were incubated with WT (n = 29) or 
PGRN-deficient (KO; n = 36) BMDMs with (LPS/IFN-) or without (Non) LPS 
and IFN- for 5 d. Cell death was assessed with PI staining. (top) Represen-
tative images. (bottom) Quantitative evaluation is expressed as the percent-
age of PI staining relative to maximal PI staining (Max) induced with 0.1% 
Triton X-100. The results are means ± SEM from five independent experi-
ments. *, P < 0.001 using the Student’s t test. Bar, 1 mm. (B) Activated  
microglia-induced cell death in hippocampal slices. Slices (n = 12 per 
group) from WT or PGRN-deficient mice were incubated with 10 ng/ml 
GM-CSF (3 d), followed by stimulation with LPS and IFN- in the presence 
of 10 µg/ml anti–IL-10 or control IgG for 3 d. Cell death was measured as in 
A. The results are means ± SEM from three independent experiments. *,  
P < 0.002 using the Student’s t test. (C) Effect of OGD on hippocampal 
slices from PGRN-deficient (KO) and WT mice (n = 6). Slices were cultured 
for 2 wk, followed by OGD treatment. Neuronal viability was assessed by PI 
staining before and after OGD. Maximal neuronal death was induced by 
exposure to 1 mM NMDA after OGD treatment. The results are means ± SEM 
from three independent experiments. *, P < 0.001 using the Student’s t test.JEM VOL. 207, January 18, 2010 
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plates with glycerol as the only carbon source. This step is negative selection, 
as DOG phosphorylated by galactokinase is nonmetabolizable and therefore 
toxic. The last step was to insert a negative selection cassette for diphtheria 
toxin/ampicillin into the sequence after the last exon of the pgrn gene with the 
selection of both kanamycin- and ampicillin-resistant recombinants.
Generation of all-tissue PGRN knockout mice. 10 µg of the BAC tar-
geting vector was linearized at a unique PISce-I site and electroporated into 
C2J embryonic stem (ES) cells with the C57BL/6 genetic background. 6 out 
of 96 ES cell clones selected with G418 and diphtheria toxin were identified 
as positive for homologous recombination by ScaI Southern blotting using 5 
and 3 probes. Three positive ES clones were injected into C57BL/6 blasto-
cysts by the Mouse Genetics Core Facility at Weill Cornell Medical Col-
lege/Memorial Sloan-Kettering Cancer Center. Chimeras were identified 
and crossed with C57BL/6J to obtain the germline-transmitted heterozy-
gous floxed mice (pgrnflox/+) identified by ScaI Southern analysis. The hetero-
zygous floxed mice are in a pure C57BL/6 background. Mating between 
two heterozygous mice generated homozygous floxed mice (pgrnflox/flox). 
BAC recombineering machinery was provided by N. Copeland (National 
Cancer Institute, Bethesda, MD). The BAC modifications were made in a 
modified bacterial strain, SW102. This strain contains the  prophage recom-
bineering system and deficient galactokinase (galK) gene. The three-step strat-
egy for making this targeting vector is as follows. First, a PCR product 
containing a loxP site fused with a flippase recombination target–flanked neo-
mycin/kanamycin (neo/kan) gene was introduced into the BAC clone and 
targeted into intron 4. The two 70 bp’s of sequences homologous to the tar-
geting site at both ends of this PCR product enabled precise targeting/
homologous  recombination.  Kanamycin-resistant  recombinants  were  se-
lected. The second step was to insert a single loxP site into the 5 end of the 
promoter region using galactose positive/negative selection. In brief, the galK 
cassette, containing homology to the region 5 of the pgrn promoter, was in-
serted into the BAC by homologous recombination. The recombinant bacte-
ria grew on minimal media with galactose as the only carbon source (positive 
selection). Then the galK cassette was substituted by an oligonucleotide with 
homology to the regions flanking the galK cassette by selecting against bacteria 
with the galK cassette by resistance to 2-deoxy-galactose (DOG) on minimal 
Figure 7.  Increased ubiquitination and phosphorylation of TDP-43 in the PGRN-deficient brain. (A) Enhanced ubiquitin immunostaining in the 
hippocampus of old PGRN-deficient mice. Sections from 18-mo-old WT and PGRN-deficient (KO) mice (n = 5) were stained using antibody against ubiq-
uitin. Representative sections from two different mice in each group are shown. Bar, 80 µm. (B) Phosphorylation of TDP-43 and its cytosolic translocation 
in aged PGRN-deficient (KO) mice. Hippocampal and thalamic sections from 18-mo-old WT and PGRN-deficient mice (n = 5) were stained with antibodies 
against TDP-43 (top) or phosphorylated TDP-43 (bottom). Bars: (left and middle) 80 µm; (right) 12 µm.126 Dysregulated inflammation in progranulin deficiency | Yin et al.
Phagocytosis assay. This assay was performed according to the manufac-
turer’s protocol (Invitrogen). BMDMs were plated into 96-well black plates 
at 105 cells/well (BD) in 100 µl of complete DMEM and incubated at 37°C 
for 2 h. After the culture medium was removed, 100 µl of sonicated fluores-
cent-labeled Escherichia coli was added to all wells for another 2 h. The E. coli 
suspension was then removed, and 100 µl of Trypan blue was added for 1 
min at room temperature and then aspirated. We measured fluorescence at 
480 nm excitation/520 nm emission and calculated relative fluorescence by 
subtracting the fluorescence of control wells containing macrophages but 
without E. coli and the fluorescence from wells containing E. coli but with-
out macrophages. Each group included four wells.
RT-PCR and quantitative real-time RT-PCR. PGRN expression in 
different organs was determined via RT-PCR using RNA from organs of 
2-mo-old WT and PGRN-deficient mice as templates, and amplified with 
a primer set that covers exons 7–10 (forward primer, 5-CTGTCGTGTGC-
CCTGATGCTAAG-3;  reverse  primer,  5-CCCCAGTCCCCAGAATT-
GAGTTTG-3). To quantify PGRN expression in the brain, the brain was 
lysed  in  TRIzol  (Invitrogen)  and  total  RNA  was  extracted  with  the 
RNeasy Mini Kit (QIAGEN). 100 ng RNA was transcribed into cDNA 
with a random hexamer. Real-time RT-PCR was performed on a se-
quence detection system (ABI PRISM 7900HT; Applied Biosystems) using 
a primer set that covers exons 6 and 7 (forward primer, 5-GTTCCCTGC-
ACAAAAGACCAA-3; reverse primer, 5-GGGTCTTAGCATCAGG-
GCAC-3; Taqman probe, 5-AGGGCAGTGTCTTTGCCTTTTTCT-
GTCG-3).  To  determine  cytokine  expression  in  macrophages,  cells  were 
stimulated with LPS. At various times after stimulation, total RNA was extracted 
and reverse transcribed, and real-time PCR was performed as described. The 
primer sequences for cytokines in real-time RT-PCR are as follows: TNF- 
(forward primer, 5-TGCTTGTTGACAGCGGTCC-3; reverse primer, 
5-ACTGGCCATCGTGGAGGTAC-3; probe, 5-AGGGCAGTGTG-
TTACGTGCAGTGACAA-3), MCP-1 (forward primer, 5-GAGCATC-
CACGTGTTGGCT-3; reverse primer, 5-TGGTGAATGAGTAGCAGCA-
GGT-3; probe, 5-AGCCAGATGCAGTTAACGCCCCACT-3), IL-12P40 
(forward primer, 5-GAGCAGTAGCAGTTCCCTGA-3; reverse primer, 
5-TCCAGTGTGACCTTCTCTGCA-3; probe, 5-TCTCGGGCAG-
TGACATGTGGAATGG-3), IL-6 (forward primer, 5-CCCAATTTC-
CAATGCTCTCC-3;  reverse  primer,  5-TGAATTGGATGGTCT-
TGGTCC-3;  probe,  5-AACAGATAAGCTGGAGTCACAGAAGGAG-
TGGC-3),  GAPDH  (forward  primer,  5-GGGAAGCCCATCACCAT-
CTT-3; reverse primer, 5-ACATACTCAGCACCGGCCTC-3; probe, 
5-AGCGAGACCCCACTAACATCAAATGGG-3),  and  IL-10  (forward 
primer, 5-AGACCCTCAGGATGCGGC-3; reverse primer, 5-CCACT-
GCCTTGCTCTTATTTTCA-3; probe, 5-AGGCGCTGTCATCGAT-
TTCTCCCCT-3). For nascent IL-10 transcript determination, we used a 
primer set spanning the boundary of exon 2/intron 2 (forward primer, 
5-AAGGACCAGCTGGACAACAT-3; reverse primer, 5-TTCACAA-
CCCTTGACTGCTG-3). The amount of mRNA was expressed as copies   
of mRNA/copy of GAPDH mRNA.
ELISA. Day 6 BMDMs were harvested and replated into a 96-well plate at 
100,000 cells/well. 2 h after plating, the cells were stimulated with LPS. At 
12, 24, or 48 h after stimulation, the medium was collected and measured 
for cytokine levels with ELISA kits from R&D Systems according to the 
manufacturer’s protocol.
Hippocampal slice culture and BMDM-induced hippocampal cell 
death. Hippocampi were dissected aseptically from 6-d-old male WT and 
PGRN-deficient pups. 350-µm coronal slices were obtained using a McIlwain 
Tissue Chopper (Vibratome Company). The slices were placed onto a Mil-
licell culture insert and cultured for 13 d in medium containing 25% horse 
serum, 50% Eagles’ basal medium, 25% HBSS, and 5 mg/ml glucose. Me-
dium was changed twice a week. To induce cell death in slices with activated 
BMDMs, slices were incubated with 105 BMDMs for 5 d in the absence or 
presence of 5 µg/ml LPS and 100 U/ml IFN-. Cell death in hippocampal 
CAG-Cre mice (four backcrosses to the C57BL/6 background from CD1 
origin) were purchased from the Mouse Genetics Core Facility at Weill 
Cornell Medical College/Memorial Sloan-Kettering Cancer Center. Breed-
ing of pgrnflox/+ or pgrnflox/flox mice with CAG-Cre mice resulted in both 
Cre-positive and -negative mice with ubiquitous deletions of the pgrn gene 
and the neo/kan cassette. Experiments were performed using age- and sex-
matched homozygous PGRN-deficient (Cre-negative) mice and their WT 
littermates. Animal studies were approved by the Institutional Animal Care 
and Use Committee of Weill Cornell Medical College.
Immunohistochemistry. Age- and sex-matched PGRN-deficient mice 
and their WT littermates were anesthetized with sodium pentobarbital and 
transcardially perfused with 0.9% saline followed by 4% paraformaldehyde 
(PFA) in PBS, pH 7.4. The brains were dissected out, postfixed in 4% PFA 
for 24 h, and cryopreserved in 30% sucrose/PBS for 48 h. Snap-frozen brains 
were embedded in tissue embedding freezing medium and sectioned at a 40-
µm thickness using a cryostat. Coronal sections were collected in PBS and 
processed free floating for immunohistochemistry.
Coronal brain sections spanning the cortex, thalamus, and hippocampus 
were washed in PBS, and endogenous peroxidase was quenched by incuba-
tion in 3% hydrogen peroxide/10% methanol solution for 10 min. Sections 
were washed in PBS and blocked in 10% normal goat serum (NGS), 0.1% 
Triton X-100 in PBS for 1 h at room temperature. Next, sections were in-
cubated with various antibodies: rabbit anti-PGRN (1:1,000; Zhu et al., 
2002), rat monoclonal anti-CD68 (1:500; AbD Serotec), mouse monoclonal 
antiubiquitin (1:50,000; Millipore), rabbit polyclonal anti-GFAP (1:2,000; 
Dako), mouse monoclonal anti–phospho–TDP-43 (pS409/410; 1:500; pro-
vided by H. Akiyama, M. Hasegawa, and T. Arai, Tokyo Institute of Psy-
chiatry, Tokyo, Japan; Inukai et al., 2008), and rabbit polyclonal anti–TDP-43 
(Proteintech) in 2% NGS, 0.01% Triton X-100 in PBS for 16 h at 4°C. Sec-
tions were washed in PBS and incubated with appropriate biotinylated sec-
ondary antibodies (Jackson ImmunoResearch Laboratories, Inc.) in PBS for 
1 h at room temperature. After incubation in streptavidin ABC enhancer so-
lution (Vector Laboratories) for 30 min at room temperature, immunostain-
ing  was  visualized  with  diaminobenzidine  (DAB;  Sigma-Aldrich)  as  the 
chromogen. Sections were washed and mounted on precoated slides (Super-
frost Plus; VWR) and allowed to air dry. The sections were further counter-
stained with either cresyl violet acetate or thionin (Sigma-Aldrich). The 
slides were dehydrated in ascending series of ethanol, passed through xylene, 
and coverslipped with DPX mounting media (Electron Microscopy Sci-
ence). Images were acquired using a digital camera (Coolpix 5000; Nikon).
Quantification of activated microglial cells and GFAP-reactive as-
trocytes. Microglial activation was quantitated by counts of CD68+ cells 
exhibiting  prominent  amoeboid  or  activated  morphology  evident  from 
DAB  chromophore–stained  sections,  as  previously  described  (Reynolds   
et al., 2007). GFAP-reactive astrocytes were counted in a similar fashion. 
Cell counts were compiled in an unbiased manner within the hippocampus, 
cortex, and thalamus by using Stereoinvestigator software (Microbrightfield) 
and expressed as cell numbers per square millimeter.
Western blotting for PGRN. Day 6 BMDMs were harvested and replated 
into a 6-well plate with two million cells/well in DMEM with 10% FBS. On 
the next day, the medium was changed into serum-free DMEM with or 
without additional stimulation. The conditioned medium was collected 48 h 
later, spun at 300 g for 5 min to remove cells, and precipitated with 20% tri-
chloroacetic acid. The protein pellet was washed in 100% acetone and boiled 
immediately in 2× SDS Laemmli loading dye. The antibody anti-PGRN 
was as previously described (Zhu et al., 2002).
Culture of BMDMs. Bone marrow cells flushed from mouse femurs (day 
0) were cultured in DMEM supplemented with 20% L929 conditioned me-
dium and 20% heat-inactivated FBS for 6 d, with fresh medium replenished 
on day 4. Day 6 BMDMs were harvested in ice-cold PBS and replated ac-
cording to different experimental purposes.JEM VOL. 207, January 18, 2010 
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